Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5

Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5

US Patent 6451982 · Granted Sep 17, 2002

Estimated economic value: $99,496,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies and variants thereof against PD-L12024
Single-domain antibodies against LAG-3 and uses thereof2024
Single-domain antibodies and variants thereof against TIGIT2024
Single-domain antibodies and variants thereof against PD-12023
Antibodies and variants thereof against TIGIT2023
Single-domain antibodies and variants thereof against PD-L12023
Compositions and methods using a single-domain antibody binding transferrin and 2022
Single-domain antibodies and variants thereof against CTLA-42022
Multispecific antigen binding proteins and methods of use thereof2022
Chimeric antigen receptors based on single domain antibodies and methods of use 2021
C.difficile toxin B CROP domain peptides, antibodies and complexes thereof2015
Method of reducing total cholesterol level by administering matrilin-2 polypepti2015